27 Feb 2024 07:00
27 February 2024
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF FULL YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Full Year Results for the year ended 31 December 2023 on Wednesday 27 March 2024.
A management presentation for research analysts will be delivered at 2:00pm GMT through a webcast facility. To register to attend or request details, RSVP to biopharmacredit@buchanan.uk.com.
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 333 300 1950
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
Biopharma Cred. (BPCR)